DRIEHAUS CAPITAL MANAGEMENT LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 274 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.

Quarter-by-quarter ownership
DRIEHAUS CAPITAL MANAGEMENT LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$19,893,643
+6.3%
520,776
+0.4%
0.26%
+9.7%
Q2 2023$18,718,779
-2.1%
518,957
+3.7%
0.24%
-11.9%
Q1 2023$19,120,205
-75.0%
500,660
-62.7%
0.27%
-76.5%
Q4 2022$76,392,745
+43.5%
1,342,579
-0.3%
1.14%
+41.3%
Q3 2022$53,236,000
-5.7%
1,346,386
+5.0%
0.81%
-11.8%
Q2 2022$56,430,000
+67.6%
1,282,492
+51.9%
0.91%
+121.3%
Q1 2022$33,661,000
+43.1%
844,063
+44.3%
0.41%
+72.1%
Q4 2021$23,519,000
-30.4%
584,910
-29.6%
0.24%
-40.1%
Q3 2021$33,809,000
+31.4%
831,094
+46.7%
0.40%
+17.6%
Q2 2021$25,723,000
+35.6%
566,459
+24.5%
0.34%
+21.8%
Q1 2021$18,969,000
+55.9%
455,013
+59.7%
0.28%
+42.1%
Q4 2020$12,170,000
+75.5%
284,946
+8.0%
0.20%
+38.7%
Q3 2020$6,934,000
+4.7%
263,847
+6.8%
0.14%
-11.8%
Q2 2020$6,623,000
+53.7%
247,032
+3.1%
0.16%
+11.8%
Q1 2020$4,309,000239,5310.14%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,506,473$61,283,0005.13%
First Light Asset Management, LLC 1,477,496$60,105,0003.96%
SNYDER CAPITAL MANAGEMENT L P 3,427,476$139,430,0003.69%
DOHENY ASSET MANAGEMENT /CA 80,400$3,271,0002.34%
Redwood Investments, LLC 619,766$25,212,0002.11%
HighMark Wealth Management LLC 53,341$2,170,0001.60%
SILVERARC CAPITAL MANAGEMENT, LLC 60,170$2,448,0001.38%
Third Security, LLC 168,604$6,859,0001.33%
Taylor Wealth Management Partners 87,654$3,566,0001.27%
Penn Capital Management Company, LLC 290,394$11,813,0001.19%
View complete list of HALOZYME THERAPEUTICS INC shareholders